Abstract: Oral Carcinogenicity and Toxicity of 2-Amino-4-chlorophenol in Rats: Kazunori YAMAZAKI, et al. Japan Bioassay Research Center, Japan Industrial Safety and Health AssociationObjectives: This study was carried out to clarify the subchronic and chronic toxicity, and carcinogenicity of 2 -a m i n o -4 -c h l o r o p h e n o l ( A C P ) . M e t h o d s : Carcinogenicity, and chronic and subchronic toxicity of ACP were examined by feeding 10 rats of both sexes ACP-containing diet at a dose level of 0 (control), 512, 1,280, 3,200, 8,000 or 20,000 ppm (w/w) for 13 wk and 50 rats of both sexes at a dose level of 0, 1,280, 3,200 or 8,000 ppm for 2 yr. Results: The 13-wk oral subchronic toxicity of ACP was characterized by proliferative lesions leading to development of tumors in the forestomach and urinary bladder and by erythrocyte toxicity as evidenced by decreases in red blood cell counts, hemoglobin and hematocrit and concurrent increases in methemoglobin levels and reticulocyte counts. Both simple and papillary and/or nodular types of transitional cell hyperplasias were observed in the urinary bladder of ACP-fed male rats. The proliferative lesions appeared at higher doses of ACP after the 13-wk administration than clear erythrocyte toxicity did. The 2-yr oral administration of ACP significantly increased incidences of squamous cell papillomas and carcinomas in the forestomach of male and female rats and transitional cell carcinomas in the urinary bladder of male rats. These tumor incidences increased dose-dependently. Notably, clear signs of erythrocyte toxicity were not evident after the 2-yr administration of ACP. Conclusion: Clear evidence of carcinogenic activity of ACP was shown in male and female rats. These data might be useful for the health risk assessment of workers exposed to ACP. (J Occup Health 2009; 51: 249-260) 
2-Amino-4-chlorophenol (ACP) is used as an intermediate in the chemical and pharmaceutical
industries, and as a raw material in dye manufacture 1, 2) . The annual production of ACP in Japan was reported to be 500 tons in 2006 1) . For industrial production of ACP, 2,5-dichloronitrobenzene is converted to 4-chloro-2-nitrophenol by reaction with sodium hydroxide, followed by reduction with iron, hydrazine or hydrogen in the presence of Raney nickel or platinum catalysts 3) . Excessive exposure of workers to ACP in the manufacturing process is unlikely to occur, because ACP is produced in a closed system. However, the possibility that workers might be exposed to ACP during other processes, including packing of synthesized ACP or cleaning or repairing of the ACP-synthesizing reactor, cannot be ruled out.
No epidemiological study on the health effects of occupational exposure to ACP has been reported 2) . ACP is reported to possess a stimulative property that causes irritation and contact dermatitis [4] [5] [6] [7] . Two medical examination studies showed contact hypersensitivity to ACP in the patch test among workers handling ACP 6) and a pronounced increase in hemoglobins X and Y and methemoglobin in the erythrocytes of production workers handling aromatic compounds including ACP 8) . Experimental toxicology studies on ACP are very few 2) , but it has been reported that bacterial mutagenicity 9, 10) and mammalian chromosome abnormality 11) of ACP are positive with or without S9 activation. ACP has been evaluated as one of the existing chemical substances with positive mutagenicity, according to the Labour Standards Bureau Notification in Japan, which requires that occupational health countermeasures be taken to protect workers from exposure to mutagenic substances 12) . No bioassay study of rodent carcinogenicity and chronic toxicity for ACP has been reported 2) . Carcinogenic potential and classification of ACP have not been evaluated by the International Agency for Research on Cancer (IARC), the Japan Society for Occupational Health (JSOH), the American Conference of Governmental Industrial Hygienists (ACGIH) or the German Research Foundation (DFG). A 2-yr bioassay study of rodent carcinogenicity is urgently needed for evaluation of the carcinogenic potential of ACP, since ACP was reported to show positive bacterial mutagenicity and structural and numerical chromosome aberrations [9] [10] [11] . The present studies consisted of both a subchronic toxicity study and a carcinogenic and chronic toxicity study, feeding rats of both sexes an ACP-containing diet for 13 wk and 2 yr, respectively. The 13-wk study was undertaken to characterize subchronic toxicity, including possible precursor lesions which might lead to development of neoplasms, and to determine an appropriate range of ACP dose levels for the 2-yr carcinogenicity study. The 2-yr study was undertaken to characterize the dose-response relationships of rat carcinogenicity and chronic toxicity induced by 2-yr oral administration of ACP in feed. The present data for doseresponse relationships for two different types of tumors obtained with rats are discussed for their validity in extrapolations to lower dose levels of environmental relevance and to human cancers, for use in risk assessment.
Materials and Methods
The present studies were conducted with reference to two OECD Guidelines: Testing of Chemicals 408 "Subchronic oral toxicity-Rodent: 90-day study" 13) and for Testing of Chemicals 451 "Carcinogenicity Studies" 14) . These studies were approved by the ethics committee of the Japan Bioassay Research Center (JBRC), and performed in conformity with the OECD Principles of Good Laboratory Practice 15) .
Test substance ACP of guaranteed grade (>99.1% pure) was obtained from Wako Pure Chemical Industries, Ltd (Osaka, Japan). The ACP was analyzed for purity and stability by gas chromatography before and after its use. The GC analysis indicated that neither impurities nor degradation products were detected in the test substance.
Animals and husbandry
The animals were cared for in accordance with a guide for the care and use of laboratory animals 16) . Four-weekold F344/DuCrlCrlj rats (SPF) of both sexes were purchased from Charles River Japan, Inc (Kanagawa, Japan). After 2-wk quarantine and acclimation, the animals were allocated by a stratified randomization procedure into body weight-matched, ACP-fed and control groups. The 13-wk study consisted of 5 dosed groups and one control group, each comprising 10 rats of both sexes. The 2-yr study consisted of 3 dosed groups and one control group, each comprising 50 rats of both sexes. 
Diet preparation and feeding
For the 13-wk study, a diet containing 512, 1,280, 3,200, 8,000 or 20,000 ppm ACP (w/w) was prepared by mixing ACP with γ irradiation-sterilized CRF-1 powdered diet (Oriental Yeast Co., Tokyo, Japan) in a spiral mixer for 5 min, after which it was stored at 7°C until use. For the 2-yr study, a diet containing 1,280, 3,200 or 8,000 ppm ACP was prepared by the same method. The high dose level of 8,000 ppm was chosen, so as not to exceed the maximum tolerated dose (MTD) on the basis of the body weight gain and subchronic toxicity seen in the 13-wk study. We used the same MTD criteria as those set for 2-yr carcinogenicity studies in the guidelines of the National Cancer Institute (NCI) 17) and the IARC 18) . The powdered diet containing ACP was prepared at intervals of 2 wk and stored in a refrigerator for its use during the 13-wk and 2-yr administration periods. The feeder filled with ACP-containing or control diet in individual cages was exchanged twice a week. ACP concentrations in the p o w d e r e d d i e t w e r e d e t e r m i n e d b y l i q u i d chromatography, and were found to range from 93.4 to 106.0% of the target concentrations at the time of preparation. These initial concentrations decreased to 90.3 to 97.5% on the 15th day after preparation, when the concentrations at the time of preparation were taken as 100%. The animals were fed diets containing ACP at different concentrations or diet only as a control throughout the 13-wk and 2-yr administration periods, starting at the age of 6 wk.
Clinical observations and analysis, and pathological examinations
The rats were observed daily for clinical signs and mortality. Body weight and food consumption were measured once a week for the 13-wk study, and once a week for the first 14 wk of the 2-yr administration period and every 4 wk thereafter for the 2-yr study. All animals underwent complete necropsy. Urinary parameters were measured in the last week of the 13-wk administration period or the 2-yr administration period with Ames reagent strips (Multistix, Simens Healthcare Diagnostics, Inc., USA). For hematology and blood biochemistry, blood samples were collected under ether anesthesia at terminal necropsy after overnight fasting. Hematological parameters were measured with an Automatic Blood Cell Analyzer (ADVIA 120, Bayer Co., USA). Blood levels of methemoglobin were determined only for the 13-wk subchronic study with a CO-oximeter (CIBA-CORNING 270, Bayer Co., USA). Blood biochemical parameters were measured with an Automatic Analyzer (HITACHI 7080, Hitachi Ltd., Japan). Organs were removed, weighed and examined for macroscopic lesions. All organs and tissues indicated in the OECD test guidelines 13, 14) were examined for histopathology in all animals. The tissues for microscopic examination were fixed in 10% neutral buffered formalin and embedded in paraffin. Tissue sections of 5 µm in thickness were prepared, and stained with hematoxylin and eosin (H & E).
Statistical analysis
Incidences of non-neoplastic lesions and urinary data were analyzed by Chi-square test. Incidences of neoplastic lesions were statistically analyzed with Fisher's exact test. The positive trend of the dose-response relationship for the neoplastic incidences was analyzed by Peto test 19) . Body weight, food consumption, organ weights, and hematological and blood biochemical parameters were analyzed by Dunnett's test. The KaplanMeier method 20) and the log-rank test 21) were used to test the statistical significance of the survival rates between any ACP-fed rat of either sex and the respective control.
Results

Thirteen-week study
Survival, food consumption, chemical intake, body and organ weights and clinical signs: All ACP-fed rats of both sexes survived to the end of the 13-wk administration period. Terminal body weight was significantly decreased in the rats of both sexes fed 20,000 ppm and in the male rats fed 8,000 ppm (Table 1) . Food consumption was significantly lowered only in the male rats fed 20,000 ppm ( Table 1) . Amounts of daily ACP intake per body weight increased proportionally at the same ratio as the stepwise increase of 2.5-fold in the ACP concentrations of the diet.
Macroscopic examination at terminal necropsy revealed that all 20,000 ppm-fed rats of both sexes had both enlarged spleen and thickened forestomach wall (Table 2 ). Relative weights of lungs, kidneys, spleen and liver were significantly increased in the male rats fed 3,200 ppm and above, except for the lung and spleen at 3,200 ppm. The ACP-fed female rats exhibited a statistically significant increase in relative spleen and liver weights at 8,000 and 20,000 ppm and in relative kidney weight at 20,000 ppm.
The increase in methemoglobin levels attained statistical significance in the male rats fed 8,000 and 20,000 ppm and in the 20,000 ppm-fed females (Table  2) . A significant increase in reticulocyte counts was found in the male rats fed 1,280 ppm and above and in the females fed 3,200 ppm and above. Red blood cell counts (RBC) were significantly decreased in the males fed 3,200 ppm and above and in the females fed 1,280 ppm and above. Hemoglobin concentration (Hb) and hematocrit (Ht) were significantly decreased in the male and female rats fed 3,200 ppm and above, except for Ht in the 3,200 ppm-fed females. The plasma level of total bilirubin was significantly increased in the 20,000 ppm-fed rats of both 9.7 ± 0.4 9.7 ± 0.8 9.7 ± 0.9 9.5 ± 0.4 9.2 ± 0.6 9.0 ± 0.5 Chemical intake (g/kg bw/day) -0.033 ± 0.001 0.083 ± 0.004 0.205 ± 0.006 0.513 ± 0.016 1.316 ± 0.034
Mean ± SD of all animals averaged over the 13-wk administration period. * and **: Significantly different at p≤0.05 and p≤0.01 by Dunnett's test, respectively.
sexes. No hematuria occurred in any group of either sex fed ACP. Histopathology: In the forestomach, hyperplasia was observed in all rats of both sexes fed 8,000 and 20,000 ppm, while the incidence of erosion/ulcer was significantly increased in the 20,000 ppm-fed females ( Table 3 ). The forestomach hyperplasia was characterized by diffuse proliferation of squamous cell epithelium with hyperkeratinization. Papillary projection of the hyperplastic epithelium into the stomach lumen and basal cell proliferation were observed in the severe cases of hyperplasia ( Fig. 1 ). In the urinary bladder, the incidence of transitional cell hyperplasia was significantly increased in the 20,000 ppm-fed male rats (Table 3) , and two morphologically different types of hyperplasias, i.e., simple and papillary and/or nodular types (PN), were 45.6 ± 0.6 45.9 ± 1.0 45.5 ± 0.8 44.5 ± 0.9* 44.0 ± 0.6** 42.3 ± 0.8** Reticulocyte counts (%) 1. 
Total bilirubin (mg/dl) 0.14 ± 0.02 0.14 ± 0.02 0.14 ± 0.03 0.19 ± 0.14 0.15 ± 0.02 0.17 ± 0.02* Values are expressed as mean ± SD. * and **: Significantly different at p≤0.05 and p≤0.01 by Dunnett's test, respectively. RBC: Red blood cell counts, Hb: Hemoglobin concentration. Body weight was measured at terminal necropsy after overnight fasting.
found (Fig. 2 ). An increase in the number of transitional epithelium layers to six or more layers was observed in the simple hyperplasia. The PN hyperplasia was characterized by papillary projection of the transitional cell epithelium with a fibrovascular stroma into the bladder lumen and/or by proliferation of transitional cells arranged in a solid island that appeared in the transitional epithelium or extended into the lamina propria. All the PN hyperplasias were accompanied by the simple hyperplasia. Notably, crystalline or amorphous precipitate could not be detected in the urinary bladder of male rats fed 20,000 ppm for 13 wk. Swelling of the transitional epithelium in the urinary bladder, indicating a degenerative change in the transitional cells, occurred in the 20,000 ppm-fed rats of both sexes (Table 3) . Splenic lesions including hemosiderin deposition, extramedullary hematopoiesis and erythrocyte engorgement occurred with statistical significance in the rats of both sexes fed 3,200 ppm and above, except for extramedullary hematopoiesis in the 3,200 ppm-fed females (Table 3) . No treatment-related lesion was observed in other organs, including the lung, kidney and liver, in the ACP-fed rat groups of either sex.
Two-year study
Survival, food consumption, body and organ weights and clinical signs: Terminal survival rates were 66%, 76%, 78% and 78% for the control, 1,280, 3,200 and 8,000 ppm-fed males and 84%, 90%, 92% and 80% for the control, 1,280, 3,200 and 8,000 ppm-fed females, respectively. These results indicate that there was no significant difference in the terminal survival rates between any ACP-fed groups of either sex and the respective control. As shown in Table 4 , there was no significant difference in terminal body weight between any ACP-fed male group and the male control, but both 3,200 and 8,000 ppm-fed female rats exhibited significant decreases in terminal body weight of 7% and 13%, respectively, as compared with the female control. Food consumption was significantly lowered in the male rats fed 3,200 and 8,000 ppm and in the females fed 8,000 ppm. The 2-yr averaged amount of daily ACP intake per body weight increased proportionally at the same ratio as the stepwise increase of 2.5-fold in the ACP concentrations of the diet.
Macroscopic examination at terminal necropsy revealed a dose-dependent increase in incidences of forestomach nodules in the ACP-fed rats of both sexes ( Table 4 ). The relative kidney weight increased dosedependently in both sexes and attained statistical significance in the 8,000 ppm-fed males and in the females fed 3,200 and 8,000 ppm. No dose-related increase in the relative weight of lungs, spleen or liver was found in either ACP-fed males or females.
Except for a clear decrease in RBC in the 8,000 ppmfed females (Table 4) , no dose-related changes in the hematological or blood biochemical parameters were found in any group of either sex fed 1,280, 3,200 or 8,000 ppm, as compared with the respective control (data not shown). Indeed, the female RBC value was greater at 3,200 ppm than at 1,280 ppm, suggesting no doseresponse relationship at low dose levels. No hematuria occurred in any ACP-fed group of either sex. Histopathology: As indicated by Fisher's exact test, statistically significant increases in incidences of forestomach squamous cell papillomas were noted in the male rats fed 3,200 and 8,000 ppm and in the 8,000 ppmfed female rats, while the incidence of squamous cell carcinomas was significantly increased in the 8,000 ppmdosed male rats ( Table 5 ). The incidences of forestomach tumors increased dose-dependently as indicated by a significant positive trend by Peto test. The incidence of transitional cell carcinomas in the urinary bladder increased dose-dependently only in male rats and attained statistical significance at 8,000 ppm. These two malignant tumors did not metastasize to any other organ. The diagnostic criteria of squamous cell tumors in the forestomach and transitional cell tumor in the urinary bladder were based on the International Classification of Rodent Tumours 22) and Monographs on Pathology of Laboratory Animals 23, 24) and on Guides for Toxicologic Pathology 25) , respectively. The forestomach squamous cell papilloma was characterized by exophytic growth of squamous epithelium with fibrovascular stroma arranged in branched finger-like processes. The squamous cell carcinomas were morphologically well differentiated and of keratinized type (Fig. 3) . The malignant tumor was defined as invasive growth into the lamina propria or submucosal tissue. The malignant forestomach tumor was often accompanied by ulcers. The transitional cell carcinoma in the urinary bladder projected into the lumen as an exophytic growth, which was characterized by multilayer formation with irregular growth (Fig. 4) . Notably, crystalline or amorphous precipitate such as calculus could not be detected in the urinary bladder of the 8,000 ppm-fed male rats bearing transitional cell carcinoma. Significantly increased incidences of hyperplasia were noted in the forestomach of male rats given 3,200 and 8,000 ppm and in the female rats given 8,000 ppm, whereas only two cases of PN hyperplasia were observed in the urinary bladder of 8,000 ppm-fed male rats (Table 5 ). Neither statistically significant nor dose-dependent increase in the incidence of erosion/ulcer was observed in any ACP-fed rat of either sex. Neither statistically significant nor dose-dependent increase in the incidences of hemosiderin deposition, extramedullary hematopoiesis or erythrocyte engorgement in the spleen was noted in any ACP-fed rat, except for the 8,000 ppm- No. of surviving animals at the end of the 2-yr administration period. b: Mean ± SD of surviving animals averaged at the end of the 2-yr administration period. c: Mean ± SD of the values measured at intervals of 1 wk for the first 14 wk and 4 wk thereafter and averaged over the 2-yr administration period. d: Mean ± SD of body weights which were mesured at terminal necropsy after overnight fasting. fed females which exhibited slightly increased severity of hemosiderin deposition (data not shown). No significant increase in the incidence of neoplastic or nonneoplastic lesions was found in the other organs, including the kidney, of the ACP-fed rat groups of either sex.
Discussion
Subchronic toxicity and preneoplastic lesions
It was found in the present 13-wk study that the subchronic toxicity of ACP was characterized by proliferative lesions of hyperplasia in both the forestomach and urinary bladder and by erythrocyte toxicity as evidenced by decreases in the erythrocyte parameters and concurrent increases in reticulocyte counts and methemoglobin level.
A principal characteristic of the subchronic toxicity was induction of the proliferative lesion leading to development of neoplasm, which occurred in the forestomach of male and female rats fed 8,000 and 20,000 ppm and in the urinary bladder of 20,000 ppm-fed male rats. Histopathological examination revealed that there were two different types (simple and PN) of hyperplasia in the transitional epithelium of the urinary bladder. Consistently, Fukushima et al. 26) reported that 4-wk treatment of rats with an urinary bladder carcinogen, Nbutyl-N-(4-hydroxybutyl)nitrosamine, induced an irreversible type of PN hyperplasia in the urinary bladder, which led to development of an urinary bladder tumor. Therefore, the PN hyperplasia found in the urinary bladder of male rats fed ACP for 13 wk is considered to develop to the urinary bladder tumor after prolonged oral administration of ACP in feed up to 2 yr. It was noteworthy, however, that crystalline or amorphous precipitate, as a causative factor that would mechanically damage the transitional epithelium, could not be found in the urinary bladder following either 13-wk or 2-yr administration of ACP. Non-neoplastic lesions were observed only at 20,000 ppm as erosion/ulcer in the forestomach and as swelling of transitional epithelium in the urinary bladder.
Another characteristic of the ACP-induced subchronic toxicity was induction of the erythrocyte toxicity which was accompanied by hemosiderin deposition, extramedullary hematopoiesis and erythrocyte engorgement in the spleen of ACP-fed rats. These splenic lesions are considered to reflect the morphological correlates of enhanced splenic function for scavenging the damaged erythrocytes. The most sensitive sign of erythrocyte toxicity was manifested as the compensatorily increased reticulocyte counts in the 1,280 ppm-fed males, although the methemoglobin level was significantly increased only in the males fed 8,000 and 20,000 ppm and in the females fed 20,000 ppm. Tomoda et al. 8) reported that two anodic components of hemoglobins were markedly enhanced in comparison with the increased level of methemoglobin in the erythrocytes of workers handling aromatic compounds including ACP, suggesting possible oxidation and modification of intracellular hemoglobins other than the methemoglobin formation. Therefore, taken together with the large difference in the statistically significant dose level between the reticulocyte counts and the methemoglobin, it remains to be solved whether or not the formation of methemoglobin is a primary cause of the ACP-induced erythrocyte toxicity. Notably, the erythrocyte toxicity appeared at lower dose levels in the present 13-wk study than the two preneoplastic and two non-neoplastic lesions did.
Carcinogenicity and chronic toxicity
Two-yr oral administration of ACP in feed was found to significantly increase the incidences of forestomach squamous cell papillomas in the male rats fed 3,200 and 8,000 ppm and in the 8,000 ppm-fed female rats, and forestomach squamous cell carcinomas in the 8,000 ppmfed males, as well as the incidences of urinary bladder transitional cell carcinomas in the 8,000 ppm-fed males. The increases in the incidences of the two types of tumor and their combined incidences were dose-dependent as judged by a significantly positive trend according to Peto test. It was noteworthy that the organs in which the two tumors were induced were exactly the same as those in which hyperplasias were induced following 13-wk administration of ACP in feed. These results suggest that the proliferative lesions of hyperplasias that occurred in the forestomach and urinary bladder after the 13-wk administration of ACP progress from benign tumors to malignant ones in the course of prolonged administration of ACP in feed extending up to 2 yr. The morphological examination revealed the invasive growth in the forestomach squamous cell carcinomas and the multilayer formation with irregular growth in the urinary bladder transitional cell carcinomas, both of which were diagnosed as being malignant 22, 23) . However, the malignant tumors found in these two organs did not metastasize to any other organ. The significantly increased incidences of forestomach hyperplasias were noted at the same dose levels as those of forestomach tumors. On the other hand, only two cases of PN hyperplasia in the transitional epithelium were noted in the males fed ACP at 8,000 ppm for 2 yr.
The high dose level of 8,000 ppm used in the present 2-yr study was selected, predicting the MTD on the basis of both the body weight change and the subchronic toxicity in the 13-wk study. The high dose level was found to fulfill the MTD criteria set by NCI 17) and IARC 18) that the highest dose of the test agent given during the carcinogenicity study should not exceed the MTD that can be predicted to elicit signs of minimal toxicity without reducing the animals' normal longevity from toxic effects other than carcinogenicity, or no more than a 10% weight decrement, as compared to the concurrent controls. The present 2-yr study, terminal body weights of 8,000 ppmfed male and female rats were decreased by 5 and 13%, respectively, compared with the respective controls, and no significant difference in the terminal survival rate was found between any ACP-fed group of either sex and the respective control. It is considered that the recommendation regarding the 10% decrease in the body weight gain is just empirical, and that even if the decrease in body weight gain exceeded 10% in practice, the 2-yr carcinogenicity bioassay results would not be invalidated 27) . Therefore, fulfillment of the MTD criteria for the present dose levels would allow extrapolation of the present dose-carcinogenic response relationships to responses that are expected to occur at lower dose levels of environmental relevance.
It was found in the present 2-yr and 13-wk studies that clear signs of chronic erythrocyte toxicity were not evident after the 2-yr administration of ACP at 8,000 ppm and below except for the decreased RBC in the 8,000 ppm-fed female rats, whereas significant changes in the erythrocyte parameters were observed following the 13-wk administration of ACP in the males fed 3,200 ppm and above and in the females fed 1,280 ppm and above. Consistently, our previous studies 28, 29) showed the same attenuated response of erythrocytes to a potent hematotoxicant, para-chloronitrobenzene (p-CNB) by prolonged administration of p-CNB to rats from 13 wk to 2 yr. Therefore, it might be rational to infer from these results that prolonged administration of ACP in rats induced some adaptive change in erythrocytes such as formation of resistance to erythrocyte injury by hematotoxic substances, regardless of the mechanisms involved.
Genotoxicity
Our JBRC laboratory reported the data of bacterial mutagenicity and mammalian chromosome aberration for ACP 10, 11) . The bacterial mutagenicity of ACP was positive with TA100 and TA1537, only when activated with S9 10) . The chromosomal aberration assay with Chinese hamster lung cells (CHL/IU) was positive only for structural aberration without S9 activation and markedly positive for both structural and numerical aberrations including increased number of polyploid cells, when activated with S9 10) . These results can be taken to indicate that metabolites of ACP formed by the liver xenobiotic enzymes are more potently mutagenic than ACP per se. Therefore, it can be inferred that the ACP-induced carcinogenicity found in the present 2-yr study is causally related to fixing the tumor-initiating DNA damage by ACP metabolites into mutations. Furthermore, the increased number of polyploid cells in the CHL/IU chromosomal aberration assay with S9 activation 10) suggests a possibility of aneuploid cells leading to genomic instability as a causative factor for ACP-induced carcinogenesis. Therefore, a genotoxic mode of action is thought to operate in ACP-induced carcinogenesis rather than a non-genotoxic mechanism such as a cytotoxic-proliferative mode of action 30) .
Extrapolation to human cancer risk
Humans do not have the forestomach, and consideration should be given to the use of rodent forestomach tumor data for predicting the cancer risk in humans. Procter et al. 31) proposed that a weight of evidence decision criteria for use of rodent forestomach tumor data for classification of potential human carcinogenicity and cancer risk assessment included genotoxicity induction of tumors not only in the forestomach but also in the other organs, oral administration not by gavage but by drinking or feeding, and fulfillment of MTD criteria for the high dose level. Since ACP and its present carcinogenicity study fulfilled these four criteria, the ACP-induced forestomach tumors of rats were judged to be applicable to humans.
Relevance for extrapolation of the rat urinary bladder tumors to humans has also been argued 32) , since close association between chemically induced rodent urinary bladder carcinogenicity and calculus formation has been established [33] [34] [35] [36] , and since the formation of calculus by biphenyl is considered to be species-and sex-specific 37, 38) . In addition to the reported findings of positive mutagenicity of ACP [9] [10] [11] , the present 13-wk and 2-yr studies confirmed that neither the crystalline or amorphous precipitate in the urinary bladder nor the hematuria, possibly resulting from the mechanical damage of transitional epithelium by the precipitate, occurred in any ACP-fed rat of either sex. It can be inferred, therefore, that a genotoxic mode of action without formation of crystalline or amorphous precipitate in the urinary bladder operates in ACP-induced urinary bladder carcinogenesis. It is interesting to note that in the present study, the occurrence of transitional cell tumors in the urinary bladder in the 2-yr study as well as hyperplasias in the same tissue in the 13-wk study was much more pronounced in male than in female rats, although the amount of daily intake of ACP per body weight was greater in females than in males. These present findings are essentially consistent with the report that the male:female ratio for the incidence of transitional cell tumors in the urinary bladder is approximately 3:1 in humans 39) . ACPinduced carcinogenicity including male predominance of bladder tumors in rats will warrant further mechanistic investigation with the ACP-fed rat, in addition to urgent need for epidemiological studies on exposure of humans to ACP and its related compounds in workplaces.
Conclusion
The 13-wk study showed the occurrence of preneoplastic lesions of hyperplasias in both the forestomach and urinary bladder and clear manifestation of erythrocyte toxicity in the ACP-fed rats. The present 2-yr study provided novel information about the carcinogenicity of ACP as clearly evidenced by the dosedependent and significant increases in the incidences of forestomach squamous cell papillomas and carcinomas in male and female rats, and urinary bladder transitional cell carcinomas in male rats following 2-yr administration of ACP in feed. Clear signs of chronic erythrocyte toxicity disappeared after prolonged administration of ACPcontaining diet for 2 yr.
